Standard Chemical & Pharmaceutical Co (TPE:1720) Beneish M-Score: -2.80 (As of Jul. 12, 2026)


TPE:1720 Standard Chemical & Pharmaceutical Co Ltd TPE:1720
95 GF Score
Price NT$63.90
GF Value NT$70.93
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Standard Chemical & Pharmaceutical Co Beneish M-Score?

Standard Chemical & Pharmaceutical Co TPE:1720 95 Beneish M-Score is -2.80 as of Jul. 12, 2026. GuruFocus rates TPE:1720 with a GF Score™ of 95/100 and a GF Value™ of NT$70.93 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 910 Drug Manufacturers companies, Standard Chemical & Pharmaceutical Co ranks better than 74.62% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.8 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Standard Chemical & Pharmaceutical Co's Beneish M-Score or its related term are showing as below:

TPE:1720' s Beneish M-Score Range Over the Past 10 Years
Min: -2.87   Med: -2.67   Max: -2.12
Current: -2.8

During the past 13 years, the highest Beneish M-Score of Standard Chemical & Pharmaceutical Co was -2.12. The lowest was -2.87. And the median was -2.67.


Standard Chemical & Pharmaceutical Co Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Standard Chemical & Pharmaceutical Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Standard Chemical & Pharmaceutical Co Beneish M-Score Chart

Standard Chemical & Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.12 -2.59 -2.66 -2.72 -2.80

Standard Chemical & Pharmaceutical Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.72 -2.94 -3.08 -2.90 -2.80

TPE:1720 vs ZTS, UTHR: Beneish M-Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Standard Chemical & Pharmaceutical Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Standard Chemical & Pharmaceutical Co Beneish M-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Standard Chemical & Pharmaceutical Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Standard Chemical & Pharmaceutical Co's Beneish M-Score falls into.


TPE:1720
95GF Score
Standard Chemical & Pharmaceutical Co Ltd TPE:1720
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Standard Chemical & Pharmaceutical Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Standard Chemical & Pharmaceutical Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9893+0.528 * 1.0628+0.404 * 0.9657+0.892 * 1.0344+0.115 * 0.9625
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9633+4.679 * -0.071141-0.327 * 1.1027
=-2.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was NT$1,371 Mil.
Revenue was 1785.387 + 1769.689 + 1827.915 + 1640.034 = NT$7,023 Mil.
Gross Profit was 736.018 + 737.355 + 735.264 + 700.172 = NT$2,909 Mil.
Total Current Assets was NT$5,461 Mil.
Total Assets was NT$11,796 Mil.
Property, Plant and Equipment(Net PPE) was NT$4,678 Mil.
Depreciation, Depletion and Amortization(DDA) was NT$434 Mil.
Selling, General, & Admin. Expense(SGA) was NT$1,288 Mil.
Total Current Liabilities was NT$2,157 Mil.
Long-Term Debt & Capital Lease Obligation was NT$204 Mil.
Net Income was 229.207 + 307.602 + 196.179 + 194.671 = NT$928 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = NT$0 Mil.
Cash Flow from Operations was 525.096 + 510.55 + 445.413 + 285.768 = NT$1,767 Mil.
Total Receivables was NT$1,339 Mil.
Revenue was 1673.142 + 1742.442 + 1760.104 + 1613.535 = NT$6,789 Mil.
Gross Profit was 739.618 + 744.66 + 789.069 + 715.344 = NT$2,989 Mil.
Total Current Assets was NT$5,002 Mil.
Total Assets was NT$11,176 Mil.
Property, Plant and Equipment(Net PPE) was NT$4,549 Mil.
Depreciation, Depletion and Amortization(DDA) was NT$405 Mil.
Selling, General, & Admin. Expense(SGA) was NT$1,293 Mil.
Total Current Liabilities was NT$1,661 Mil.
Long-Term Debt & Capital Lease Obligation was NT$368 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(1370.646 / 7023.025) / (1339.41 / 6789.223)
=0.195165 / 0.197285
=0.9893

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(2988.691 / 6789.223) / (2908.809 / 7023.025)
=0.440211 / 0.414182
=1.0628

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (5461.464 + 4678.392) / 11795.903) / (1 - (5001.892 + 4548.939) / 11175.545)
=0.140392 / 0.145381
=0.9657

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=7023.025 / 6789.223
=1.0344

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(404.738 / (404.738 + 4548.939)) / (433.972 / (433.972 + 4678.392))
=0.081705 / 0.084887
=0.9625

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(1288.21 / 7023.025) / (1292.758 / 6789.223)
=0.183427 / 0.190413
=0.9633

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((204.019 + 2156.966) / 11795.903) / ((367.647 + 1660.932) / 11175.545)
=0.200153 / 0.181519
=1.1027

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(927.659 - 0 - 1766.827) / 11795.903
=-0.071141

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Standard Chemical & Pharmaceutical Co has a M-score of -2.80 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.80 mean?
Standard Chemical & Pharmaceutical Co (TPE:1720) has a Beneish M-Score of -2.80 as of Jul. 12, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Standard Chemical & Pharmaceutical Co and its competitors. According to the industry distribution chart, Standard Chemical & Pharmaceutical Co ranks #231 out of 910 companies in the Drug Manufacturers industry, placing it in the top 25.4%.
Is Standard Chemical & Pharmaceutical Co's Beneish M-Score too high?
Standard Chemical & Pharmaceutical Co's current Beneish M-Score is -2.80. Based on the distribution chart, Standard Chemical & Pharmaceutical Co ranks #231 out of 910 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Standard Chemical & Pharmaceutical Co has a GF Score™ of 95/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Standard Chemical & Pharmaceutical Co's Beneish M-Score compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Standard Chemical & Pharmaceutical Co ranks #231 out of 910 companies for Beneish M-Score. This puts Standard Chemical & Pharmaceutical Co in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Drug Manufacturers company?
A good Beneish M-Score depends on the Drug Manufacturers industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Standard Chemical & Pharmaceutical Co and its competitors. Standard Chemical & Pharmaceutical Co's current Beneish M-Score is -2.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Standard Chemical & Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Standard Chemical & Pharmaceutical Co (TPE:1720) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$70.93, compared to a current price of NT$63.90 — trading 9.9% below its estimated fair value. The current Beneish M-Score is -2.80. Standard Chemical & Pharmaceutical Co's overall GF Score™ is 95/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Standard Chemical & Pharmaceutical Co (TPE:1720), the current Beneish M-Score is -2.80 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Standard Chemical & Pharmaceutical Co (TPE:1720) Overvalued in 2026?

Based on GuruFocus' analysis, Standard Chemical & Pharmaceutical Co stock appears to be undervalued. The current stock price of NT$63.90 is trading 9.9% below its estimated GF Value™ of NT$70.93. GuruFocus considers Standard Chemical & Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for TPE:1720:

  • Beneish M-Score: -2.80
  • GF Value™: NT$70.93 vs. price of NT$63.90 (9.9% below fair value)
  • GF Score™: 95/100 with 2 warning signs

No single metric tells the full story. See the TPE:1720 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Standard Chemical & Pharmaceutical Co Business Description

Address No.6-20,Tuku, Sinying District, Tuku Village, Tainan, TWN, 73055
Standard Chemical & Pharmaceutical Co Ltd is engaged in the manufacturing and sales of Chinese and western medicine, cosmetics, beverage, normal instruments and medical instruments. Its segments include Medicine, Dietary supplement and Ingredients. The majority of the revenue is derived from the Medicine segment. Geographically it operates in Taiwan, Japan and Others with Taiwan generating the maximum revenue.
95GF Score

Get the complete analysis for TPE:1720

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$63.90
Price
NT$70.93
GF Value